(95), Miller LG, Kim W, Schowe S, Taylor K, Han R, Jain V, Park R, Sherman M, Fang J, Ramirez H, Ellington AD, Tamamis P, Resendiz MJE, Y. J. Zhang (co-corresponding), and Contreras L. “Selective 8-oxo-rG stalling occurs in the catalytic core of polynucleotide phosphorylase (PNPase) during degradation.” PNAS.

(94), J.P. Butalewicz, S. N. Sipe, K.J. Juetten, V. K. James, K Kim, Y. J. Zhang, T. D. Meek, and J.S. Brodbelt. “Insights into the Main Protease of SARS-CoV-2: Thermodynamic Analysis, Structural Characterization, and the Impact of Inhibitors.” Analytical Chemistry. Publisher's Version

(93), HA Hardtke, RY Moreno, and YJ Zhang. “In vitro reconstruction of site-specifically phosphorylated RNA Polymerase II to identify the recruitment of novel transcription regulators.” STAR Protocol, 5, 3, Pp. 103277. Publisher's Version

(92), Q Zhang, W Kim, S Panina, JE Mayfield, B Portz, and YJ Zhang. “Variation of C-terminal domain governs RNA polymerase II genomic locations and alternative splicing in eukaryotic transcription.” Nature Communication, 15, 7985. Publisher's Version

(91), RY Moreno, SB Panina, S Irani, HA Hardtke, R Stephenson, BM Floyd, EM Marcott, Q Zhang, and YJ Zhang. “Thr4 phosphorylation on RNA Pol II occurs at early transcription regulating 3’-end processing.” Scinece Advances, 10, 36. Publisher's Version

(90), KB Reed, W Kim, H Lu, LT Larue, S Guo, SM Brooks, M Montez, J Wagner, YJ Zhang, and HS Alper. “Evolving Dual-Trait EPSP Synthase Variants Using a Synthetic Yeast Selection System.” PNAS, 121, 35. Publisher's Version

(89), E. E. Escobar, W Yang, M. B. Lanzillotti, K.J. Juetten, S Shields, D. Siegel, Y. J. Zhang, and J.S. Brodbelt. “Tracking Inhibition of human Small C-terminal Domain Phosphatase 1 using 193 nm Ultraviolet Photodissociation Mass Spectrometry.” Journal of the American Society for Mass Spectrometry , 35, 6, Pp. 1330-1341. Publisher's Version

(88), Panina SB, Schweer JV, Zhang Q, Raina G, Hardtke HA, Kim S, Yang WJ, Siegel D, and Zhang YJ. “Targeting of REST with rationally-designed small molecule compounds exhibits synergetic therapeutic potential in human glioblastoma cells.” BMC Biology, 22, 83. Publisher's Version

(87), I Wallach, A Morrison, .., .., B Medellin, .., .., Y. Jessie Zhang, .., and A Heifets. “AI is a Viable Alternative to High Throughput Screening: a 318-Target Study.” Scientific Reports, 14, Pp. 7526. Publisher's Version

(86), S d’Oelsnitz, D Diaz, W Kim, D Acosta, M Schechter, M Minus, J Howard, H Do, T Dangerfield, J Loy, HS Alper, YJ Zhang, and AD Ellington. “Synthetic microbial sensing and biosynthesis of a branchpoint amaryllidaceae alkaloid.” Nature Communication, 15, Pp. 2084 (2024) . Publisher's Version

(85), HA Hardtke, and YJ Zhang. “Collaborators or competitors: The communication between RNA polymerase II and the nucleosome during eukaryotic transcription.” Critical Reviews in Biochemistry and Molecular Biology, 59, 1-2. Publisher's Version

(84), Wang JX, Vilbert AC, Cui C, Mirts EN, Williams LH, Kim W, Zhang YJ, and Lu Y. “Increasing Reduction Potentials of Type 1 Copper Center and Catalytic Efficiency of Small Laccase from Streptomyces coelicolor through Secondary Coordination Sphere Mutations..” Angew Chem Int Ed Engl., 62, 52. Publisher's Version

(83), R.Y. Moreno, K.J. Juetten, S.B. Panina, J.P. Butalewicz, B.M. Floyd, M.K. Venkat Ramani, E.M. Marcotte, J.S. Brodbelt, and Y. J. Zhang. “Distinctive Interactomes of RNA polymerase II phosphorylation during different stages of transcription.” iScience, 26, 9. Publisher's Version

(82), Erwin, K., R.Y. * Moreno, B-J. Baas, Y. J Zhang (co-corresponding), and C.P. Whitman. “Evolution of the fused 4-oxalocrotonate Tautomerase in the Tautomerase Superfamily: Introduction of Asymmetry.” Biochemistry, 62, Pp. 2461-2471. Publisher's Version

(81), YW Liu, NM Marshall, S Yu, W Kim, YG Gao, H Robinson, MJ Nilges, Y Zhang, SY New, and Y Lu. “Structural basis for the effects of phenylalanine on tuning the reduction potential of type 1 copper in azurin.” Inorganic Chemistry, 62, 29, Pp. 11618-11625. Publisher's Version

(80), Y. Jessie Zhang, and Philip A. Cole. “Editorial: Mechanistic Biology.” Current Opinion of Chemical Biology, 74.

(79), Lancaster EB, Johnson WH Jr, LeVieux JA, Hardtke HA, Zhang YJ, and Whitman CP. “A mutagenic analysis of NahE, a hydratase-aldolase in the naphthalene degradative pathway.” Arch Biochem Biophys., 733, Pp. 109471. Publisher's Version

(78), Blazeck J, Karamitros CS, Ford K, Somody C, Qerqez A, Murray K, Burkholder NT, Marshall N, Sivakumar A, Lu WC, Tan B., Lamb C, Tanno Y, Yemeny MS, Zhang M, McGovern K, Kumada Y, Zhang YJ, Manfredi M, Johnson KA, D'Arcy S, Stone E, and Georgiou G. “Bypassing evolutionary dead-ends and switching the rate-limiting step of a human immunotherapeutic enzyme.” Nature Catalysis, 5, Pp. 952–967. Publisher's Version

(77), Kim W, Chen TY, Cha L, Zhou G, Xing K, Canty NK, Zhang Y *(co-corresponding), and Chang WC. “Elucidation of divergent desaturation pathways in the formation of vinyl isonitrile and isocyanoacrylate.” Nature Communication, 13, 5343. Publisher's Version

(76), d’Oelsnitz S, Kim W, Burkholder NT, Javanmardi K, Thyer R, Zhang Y, Alper H, and Ellington AD. “Directed Evolution of a Generalist Biosensor Accelerates Alkaloid Pathway Engineering.” Nature Chemical Biology. Publisher's Version